ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Presentations Articles

Mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: an updated systematic review and meta-analysis of randomized clinical trials

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Amyloid and acute heart failure therapy advances

Representation of frailty in contemporary trials of heart failure medications: a systematic review and dose-response meta-analysis

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 5

Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Acute heart failure - treatment 2

Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Acute heart failure - pharmacotherapy

Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: Young Investigator Award: clinical research

ESC 365 is supported by

novartis

Explore sponsored resources